News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shenzhen Neptunus Interlong Bio-Techique Co. Ltd. Files for U.S. Test of TCM



1/18/2013 10:58:01 AM

by Richard Daverman, PhD

January 18, 2013 -- Shenzhen Neptunus Bioengineering announced that it has filed an application for a US Phase II clinical trial of Polydatin Injection. Polydatin is a Class I innovative traditional Chinese that aides microcirculation of the blood and is expected to be tested as a treatment for myocardial ischemia, cerebral ischemia, shock and other cardiovascular diseases. More details....

Stock Symbol: (SHE: 000078)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES